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In Vivo Evidence for a Bridging Role of a Collagen V
Subtype at the Epidermis–Dermis Interface
Christelle Bonod-Bidaud1,2,7, Muriel Roulet1,2,7, Uwe Hansen3,8, Ahmed Elsheikh4,8,
Marilyne Malbouyres1,2, Sylvie Ricard-Blum2,5, Cle´ment Faye2,5, Elisabeth Vaganay1,2,
Patricia Rousselle2,6 and Florence Ruggiero1,2
Collagen V is the defective product in most cases of classical Ehlers–Danlos syndrome (EDS), a connective tissue
disorder typically characterized by skin fragility and abnormal wound healing. Collagen V assembles into
diverse molecular forms. The predominant a1(V)2a2(V) heterotrimer controls fibrillogenesis in skin and other
tissues. The a1(V)3 minor form is thought to occur in skin, but its function is unknown. To elucidate its role, we
generated transgenic mice that overexpress the human a1(V)3 homotrimer in the epidermis. The transgene-
derived product is deposited as thin unstriated fibrillar material in the basement membrane zone of embryonic
and perinatal epidermis and hair follicles. Accumulation of a1(V)3-containing fibrils leads to ultrastructural
modifications at the epidermis–dermis interface and provokes changes in biomechanical properties, although
not statistically significant. Using superparamagnetic immunobeads to isolate authentic suprastructures and
protein-binding assays, we demonstrate that the homotrimer is part of a protein network containing collagen IV,
laminin-111, and the dermal collagen VI. Our data show that the homotrimer serves as a bridging molecule that
contributes to the stabilization of the epidermal–dermal interface. This finding strongly suggests that collagen V
may be expressed in skin as different subtypes with important but distinct roles in matrix organization and
stability.
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INTRODUCTION
Collagen V is a quantitatively minor component of collagen
I–rich tissues such as the dermis, tendon/ligament, bone,
blood vessel, and cornea. In contrast to cornea where the
concentration of this collagen type is relatively high
(20–25%), collagen V represents only 1–3% of the total
collagen content in skin (Fichard et al., 1995). The low
representation of collagen V in skin contrasts with the severity
of the skin phenotype in patients with classic Ehlers–Danlos
syndrome (EDS), a heterogeneous heritable connective tissue
disorder essentially caused by mutations in collagen V genes,
COL5A1 and COL5A2. Mutations in the human third chain
a3(V) (COL5A3) gene have not been reported. This disorder is
primarily characterized by soft and hyperextensible skin,
impaired wound healing with atrophic scars, and reduced
tensile strength (Malfait et al., 2005). Ultrastructural analyses
of skin biopsies of EDS patients essentially revealed defects in
collagen fibrillogenesis with a decrease in fiber density and
the presence of large irregular collagen fibers (Giunta and
Steinmann, 2000; Bouma et al., 2001).
Collagen V assembles in different isoforms that differ in
chain composition and whose in vivo significance is unclear
(Ricard-Blum and Ruggiero, 2005). The most abundant and
widely distributed isoform is the a1(V)2a2(V) heterotrimer,
but different minor forms are also expressed in tissues as
the a1(V)3 homotrimer first observed in cell cultures and
embryonic tissues (Haralson et al., 1984; Moradi-Ameli et al.,
1994). In skin, the major role of a1(V)2a2(V) heterotrimer in
the nucleation and control of collagen I/V heterofibrils has
been well documented using mouse models for EDS (Chanut-
Delalande et al., 2004; Wenstrup et al., 2004). Interestingly,
skin analysis of the pN (exon 6 deletion in Col5a2 gene)
mouse model for EDS also revealed that collagen V may have
isoform-specific roles and underscored the role of a1(V)3
homotrimer in skin development (Chanut-Delalande et al.,
2004). Along this line, in vitro fibrillogenesis experiments
showed that, unlike the heterotrimer, recombinant a1(V)3
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homotrimer did not form heterotypic fibrils when mixed with
collagen I, but polymerize into distinctly thin filaments
(Chanut-Delalande et al., 2001). The a1(V)3 homotrimer was
instead localized as thin filamentous structures at the surface
of large collagen I fibrils and did not regulate fibril assembly.
The localization of these thin fibrils indicates that the homo-
trimer can act as a molecular linker between collagen fibrils
and/or macromolecules in the extracellular matrix (Chanut-
Delalande et al., 2001). Consistent with this finding, very thin
(5–10 nm in diameter) unstriated fibrils made of collagen V
were previously reported immediately near epithelial base-
ment membranes and extending into the adjacent interstitial
matrix (Fitch et al., 1984; Modesti et al., 1984; Birk et al.,
1986; Adachi and Hayashi, 1994). However, the paucity of
collagen V homotrimer in tissues did not allow further
biochemical and functional analyses.
To further detail the in vivo assembly and function of
collagen V homotrimer in skin, we generated a transgenic
mouse line (K14-COL5A1) overexpressing the human
proa1(V) chain under the control of the keratin 14 (K14)
epidermis-specific promoter (Vassar et al., 1989). This
strategy was designed to produce the homotrimer in cells
that do not express the proa2(V), with the aim to provoke its
accumulation at the epidermis–dermis interface during skin
development. Proa2(V) mRNA were not detected in the
epidermis during mouse development (Andrikopoulos et al.,
1992), whereas proa1(V) mRNA was detected in the
ectoderm at 10.5 d.p.c. (days post coitum), but expression
ceased at 12.5 d.p.c. when epidermal cells started to
differentiate (Roulet et al., 2007). We showed that over-
expression of a1(V)3 homotrimer provokes a large increase in
the thin fibril density present underneath the epidermal
basement membrane and results in changes in the ultra-
structural and biomechanical properties of the skin. The
higher content in collagen V thin fibrils at the epidermal–
dermal interface allowed the detailed analysis of the in vivo
role of a1(V)3 homotrimer. Our findings unravel an important
role of the minor a1(V)3 molecular form in epidermis–dermis
organization and stability during mouse skin development.
RESULTS
Generation of K14-COL5A1 mice and characterization
of the transgene-derived product
Transgenic mouse lines (K14-COL5A1) overexpressing the
human proa1(V) chain in the epidermis under the control
of the K14 promoter (Vassar et al., 1989) were created and
characterized (Supplementary Figure S1 online). Correct
expression of the transgene was attested by immunofluores-
cence staining of HaCat cells transiently transfected with
the K14-COL5A1 construct, with the 18G5 antibody that
recognizes the N-terminal end of the proa1(V) chain (Bonod-
Bidaud et al., 2007; Supplementary Figure S1A and B online).
The construct was then injected into fertilized eggs to
generate the K14-COL5A1 transgenic mouse lines. Three
independent transgenic founders (Tg1-3) were identified
by PCR using specific primers; the strongest expression in
skin was observed in founder 1 (Supplementary Figure S1C
online). The tissue specificity of the K14 promoter was
checked by performing reverse-transcriptase (RT)-PCR on
RNA isolated from different tissues using primers specific for
the transgene product (Supplementary Figure S1D online).
We also checked that transgenic epidermis does not express
endogenous proa2(V), because it may form a hybrid
heterotrimeric molecule with the human proa1(V) transgene
product. We thus chemically separated the epidermis from
the dermis (Trost et al., 2007) and performed RT-PCR on
isolated epidermis and dermis RNA extracts from embryonic
(17.5 d.p.c.) and perinatal (5 days old) skin using mCol5a2
and hCOL5A1 specific primers. We showed that mCol5a2
expression is restricted to the dermis in skin, excluding a
possible production of the heterotrimer in transgenic epider-
mis (Figure 1a). Substantial expression of hCOL5A1 was
detected in the dermis (Figure 1a), suggesting that treatment
with sodium thiocyanate to separate the epidermis from the
dermis (Trost et al., 2007) did not prevent the presence of
contaminant epidermal cells, probably from hair follicle
sheath that also expresses K14, which remain attached to the
dermis. Overexpression of human proa1(V) in the epidermis
did not change significantly the expression of major skin
matrix components and signaling factor mRNAs (Col1a1,
Col6a1, Tenascin-X, Tgfb1-3) as analyzed by semiquantita-
tive RT-PCR (Figure 1b) and densitometry (not shown).
The expression of the proa1(V) homotrimer in transgenic
mice was confirmed by immunoblot analysis of 17.5 d.p.c.
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Figure 1. Transgene expression. (a, b) Skin was dissected from 17.5 d.p.c.
(days post coitum) and 5-day-old mice, both wild-type (WT) and transgenic
(Tg). (a) The epidermis (Ep) was separated from the dermis (D). Reverse-
transcriptase (RT)-PCR was performed with specific primers on (a) the dermis
and epidermis or (b) total skin. (c) Immunoblot analysis of human proa1(V)
and mouse proa2(V) expression in 17.5 d.p.c. skin embryos. Membranes
were probed with (left) 13F6 antibody or with (right) polyclonal antibodies
that recognize the murine proa2(V) chain. (d) Crude extracts (lanes 2 and 4)
and isolated suprastructural fragments (lanes 1 and 3) from mouse skin.
bp, bead pellet; ce, crude extract.
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embryo skin extracts using specific antibody to human
proa1(V) chain. After secretion, procollagen V is proteolyti-
cally processed into mature protein. Thus, different procolla-
gen V molecular forms can be identified from tissue extracts:
the proa1(V) that contains the N- and C-propeptides,
intermediate processed forms, and the proNa1(V) chain, the
latter corresponding to the mature chain. An intense band
corresponding to human proNa1(V) chain was observed in
transgenic skin extracts (Figure 1c, left panel) but not in wild-
type extracts, indicating that the transgene-derived product
was correctly produced and secreted by the epidermis. By
re-probing the membrane with antibody to mouse a2(V)
chain, a band corresponding to the a2(V) chain position was
equally detected in wild-type and transgenic skin extracts
(Figure 1c, right panel). Thereafter, crude extracts from
perinatal mouse skin containing suprastructural fragments
obtained by mechanical disruption of skin were used for the
isolation of a1(V)3 homotrimer aggregates by superparamag-
netic immunobeads. The human proa1(V) chain and the
processed pNa1(V) form were detected in crude transgenic
skin extracts (Figure 1d, lane 2), as well as in the isolated
suprastructures (Figure 1d, lane 1), whereas no signal could
be detected in wild-type mice (Figure 1d, lanes 3 and 4).
The a1(V) homotrimer is deposited in the basement membrane
zone as thin unstriated fibrils associated with ultrastructural
changes in skin
Immunohistochemical localization of the a1(V) chain was
performed in cross-sections of 5-day-old mouse skin using
the 18G5 antibody directed against the N-terminal end of
the proa1(V) chain (Bonod-Bidaud et al., 2007) and detecting
both endogenous and transgene-derived products. In wild-
type and transgenic skin, collagen V was detected in the
dermis as a weak and diffuse signal (Figure 2a). However,
the staining was substantially more intense at the dermis–
epidermis junction zone in transgenic skin (Figure 2a, top
right panel). In addition, a strong signal, undetectable in
wild-type skin, was observed around hair follicles (Figure 2a,
bottom right panel). Interestingly, hair follicles appeared
more numerous in transgenic mouse skin (Figure 2a). This
was further confirmed in cross-sections stained with Masson’s
trichrome (Figure 2b) and by scanning electron microscopy
showing hair density of 5-day-old wild-type and transgenic
mouse pelage (Supplementary Figure S2 online). Hair count
performed on depilated skin revealed that the number of hair
strands was in average 18.5% higher in K14-COL5A1
transgenic mice than in wild-type mice (Figure 2b, bright
field and histogram). The high number of hair strands in
transgenic skin can explain the substantial expression of the
transgene detected in the dermis after sodium thiocyanate
treatment (Figure 1a).
Under the transmission electron microscope (TEM), thin
unstriated fibrils (about 5 nm in diameter) are observed in
the dermal–epidermal junction zone of 17.5 d.p.c. wild-type
embryos (Figure 2c, left panel arrows) and 5-day-old mice
(Figure 2c, right panel). A particularly strong accumulation of
this thin fibrillar material was observed underneath the
dermal–epidermal junction of K14-COL5A1 transgenic skin
(Figure 2c, right panel, arrows). Interestingly, with the
increase in collagen V homotrimer thin fibrils at the basement
membrane zone, we showed that the number of hemidesmo-
somes per micrometer of apical membrane of basal epithelial
cells was in average 1.7 times higher in modified mice
(0.8 mm1 vs. 0.47 mm1 in wild-type) (Figure 2d). Immuno-
gold labeling of the dermal–epidermal junction zone of the
K14-COL5A1 transgenic skin with mAb specific to the human
proa1(V) chain (13F6) confirmed that the transgene-derived
product localizes underneath the dermal–epidermal base-
ment membrane and is deposited as thin unstriated filamen-
tous suprastructures and as a component of network-
like suprastructures (Figure 3b–d compared with wild type
Figure 3a). Interestingly, these suprastructures were decorated
with gold particles without any pretreatment with acetic
acid, indicating that collagen V homotrimer epitopes were
unmasked and readily accessible to antibody. Furthermore, in
agreement with the immunohistochemical staining, mainly
network-like suprastructures were labeled in the extracellular
matrix surrounding the hair follicles of transgenic mice
(Figure 3e and f). As expected, the dermal collagen fibrils
were not labeled at all. Overexpression of human a1(V)3
homotrimer led to other minor changes in the morphology of
basal epidermal cells. Whereas the basal layer cells of wild-
type epidermis are lined up and contiguous, lacunae were
often observed between basal cells of 17.5 d.p.c. transgenic
epidermis (Figure 2c, left panel, asterisks). Because the
presence of lacunae between cells can reflect high rate of
proliferation, epidermal basal cell proliferation was estimated
by the number of Ki-67-positive cells in transgenic skin
compared with wild type. No significant difference in
proliferation rate was observed in transgenic and wild-type
skin (data not shown).
Overexpression of a1(V)3 homotrimer modifies skin
biomechanical properties
To analyze possible alteration of the skin extensibility,
1-month-old mice were killed and held by the skin of their
back. No change in skin extensibility was observed in K14-
COL5A1 mice (in average 44mm, n¼23). However, when
the mice were held by the skin of their back for few minutes
and put back down, the fold formed by skin pinching relaxed
much slower in transgenic mice than in wild type, indicating
that overexpression of a1(V) homotrimer may alter skin
deformability.
In parallel experiments, the skin of mice was stretched
to breaking point while simultaneously measuring the
applied force and resulting extension (Supplementary
Figure S3 online). The data are plotted as stress versus strain
(Figure 4a). On average, the transgenic skin showed a flatter
slope (lower stiffness) and a lower rupture stress than the
wild-type skin. Figure 4b shows the load extension behavior
of the wild-type and transgenic skin specimens subjected to
splitting tests (Supplementary Figure S3 online). The behavior
went through three stages starting with low stiffness (low
resistance to splitting) up to an extension of approximately
1.2 to 1.4mm, followed by a higher stiffness stage up to an
extension of about 2.5mm. At the end of this stage, some of
www.jidonline.org 1843
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Figure 2. Analysis of skin structure and ultrastructure. (a) Immunolocalization of the transgene using the monoclonal 18G5 antibody in (left panel)
5-day-old wild-type (WT) and (right panel) transgenic mice (K14-COL5A1). (b, upper panel) Masson’s trichrome staining of skin cross-sections of 5-day-old WT
and transgenic mice. (b, lower panel) Light microscope micrographs of depilated 5-day-old epidermis and histogram of hair follicle counting. **Po0.01.
(c, d) Ultrastructural analysis of 17.5 d.p.c. (days post coitum) (left) and 5-day-old (right) transgenic and WT mouse skin. (c) Asterisks indicate lacunae in the
basal layer of the transgenic epidermis; arrows show the accumulation of dense unstriated fibrillar material underneath the basement membrane in transgenic
skin compared with WT. (d) Arrows indicate hemidesmosomes. Histogram of hemidesmosome (HD) counting, ***Po0.001. Fb, fibroblast; Ke, keratinocyte.
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the tissue specimens ruptured, whereas others continued to
resist additional splitting load while experiencing low
stiffness. However, no notable difference could be observed
between the two specimen types.
Collagen V homotrimer serves as a bridging molecule at the
epidermal–dermal interface
The unique location and structure of a1(V)3 homotrimer
suggest that it may serve as a molecular bridge between the
epidermis basement membrane and dermal collagen fibers.
To test this possibility, collagen V–containing suprastructures
were isolated from mechanical disrupted skin extracts using
magnetic immunobeads (Figure 5a). The isolated suprastruc-
tures had an amorphous and network-like morphology. We
showed that the human proa1(V) chain, as well as the ECM
components, collagen VI (Figure 5a (A and B) and Supple-
mentary Figure S4 online), laminin g1 (a chain of the laminin-
111) (Figure 5a (C) and Supplementary Figures S4, S5 online),
collagen IV (Figure 5a (D and E)), and tenascin-X (Figure 5a
(F)) are structural components of these networks.
We thus reasoned that a1(V)3 homotrimer is a part of a
protein network containing basement membrane compo-
nents and dermal collagen VI. To confirm this hypothesis, we
next used surface plasmon resonance (SPR) technology to
identify direct interaction with the a1(V)3 homotrimer.
Because the homotrimer is present in low amount in tissues,
we used the previously characterized recombinant a1(V)3
homotrimer that contains the entire N-propeptide (Fichard
et al., 1997) as the immobilized ligand, as the proa1(V) chain
was shown to retain a part of the N-propeptide in skin (Colige
et al., 2005). We showed that soluble pepsinized collagen VI
and IV, but not laminin, bound to recombinant proa1(V)3
homotrimer spotted onto Gold affinity chips, and the
complexes formed were stable as shown by the slow
dissociation phase (Figure 5b). However, using solid-phase
assay and purified laminin-111 (Rousselle et al., 1997), we
were able to show direct binding between immobilized
proa1(V) chain and soluble laminin-111, thus confirming the
immunogold labeling (Figure 5c). To detail the a1(V)
domain(s) binding sites, recombinant fragments of the N-
propeptide (the full-length N-propeptide Na1(V), and the
NC3 domain containing the TSPN domain and the variable
region) were further analyzed for their capacity to bind
collagens IV and VI and laminin-111. Both collagens bind to
the Na1(V) and to the NC3 domain using SPR, suggesting that
the binding sites are both located in the globular domain of
the N-propeptide, whereas no binding was obtained between
the Na1(V) and laminin-111 using solid-phase assay,
indicating that the laminin-111 binding site is located in the
C-terminal non-globular end of the N-propeptide (Figure 5c).
Combined, our data fit with a head-to-head polymerization of
the a1(V)3 monomers to bridge basement membrane compo-
nents to dermal proteins (Figure 5d).
DISCUSSION
Earlier studies have shown that the collagen V heterotrimer is
present in most tissues as a buried component in collagen I
fibrils, and that its immunodetection in tissues required the
use of epitope unmasking (Birk, 2001). However, unmasked
collagen V was also immunolocalized as thin filaments in
the immediate vicinity of basement membranes (Gay et al.,
1981; Modesti et al., 1984; Birk et al., 1986). From these
immunostainings, an anchoring function between basement
and stromal matrix was proposed for unmasked collagen V.
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Figure 3. Analysis of skin by immunogold electron microscopy. Ultrastructural analysis of the skin from (a) wild-type and (b–d) transgenic mice and hair
follicles of (e, f) transgenic mice by using an antibody against human proa1(V) chain. Arrowheads indicate representative gold particles. BM, basement
membrane; fib, dermal collagen fibrils; hs, hair shaft. Bar¼ 200nm.
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Our previous in vitro fibrillogenesis experiments strongly
suggested that the exposed collagen V in tissues corresponds
to the homotrimer collagen V subtype (Chanut-Delalande
et al., 2001). Here, by generating transgenic mice over-
expressing the collagen V homotrimer in the epidermis,
we clearly identify the a1(V)3 homotrimer as a candidate
molecule to serve bridging function in skin. This is in
agreement with previous TEM observations of the base-
ment membrane–stromal architecture (Adachi et al., 1997).
Moreover, consistent with this bridging function, the detailed
nature of direct physical interactions between collagen V
homotrimer and components of basement membrane/dermal
zone has been determined. Using superparamagnetic im-
munobead technology, which allows the characterization of
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Figure 5. Binding partners of collagen V. (a) Transmission electron microscope (TEM) analysis of suprastructures isolated with superparamagnetic
immunobeads. (A, B) Double labeling with antibodies against collagen VI (large gold particles, black arrowheads) and the human proa1(V) chain (small gold
particles, white arrowheads). (C) Double labeling with antibodies against laminin-g-1 chain (black arrowheads) and the human proa1(V) chain (white
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soluble pepsinized collagens IV and VI over spotted recombinant collagen V homotrimer. Bottom: Interactions between immobilized recombinant domains
of collagen V and collagens IV and VI. (c) Solid-phase binding assays. Soluble lanimin-111 binding to immobilized recombinant collagen V homotrimer
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native protein networks in tissues (Villone et al., 2008), we
demonstrated that collagen V homotrimer directly binds to
collagen IV–containing networks and collagen VI–beaded
filaments, and thus is part of the structural network bridging
epidermal basal membrane to dermal extracellular matrix.
Furthermore, we evidenced that direct interactions are at least
mediated by the a1(V) N-terminal recombinant domain. In
agreement with these results, we recently identified, from a yeast
two-hybrid screen, physical interactions between the a1(V)
N-propeptide and collagen VI chains (Symoens et al., 2010).
Collagens are large multimeric proteins that contain several
binding sites for different molecules. The formation of a protein
network that bridges collagen V homotrimer fibrils to collagen
IV and laminin-111 on the basement membrane side, and
collagen VI on the dermal side, is thus conceivable. Combined,
the data allow us to propose a model for the organization and
location of collagen V subtypes in skin (Figure 5d).
The striking feature of K14-COL5A1 transgenic mice was
the accumulation of thin fibrillar material composed of
collagen V homotrimer underneath the epidermal basement
membrane. Stiffness and rupture stress of the transgenic skin
were lower compared with wild type, both parameters being
influenced by the density of collagen fibers in tissues.
Collagen fiber density and organization of transgenic dermis
as judged by histology and TEM appeared normal (not
shown). Thus, the results were interpreted as a higher stiffness
of the epidermis–dermis cohesion in transgenic skin resulting
in rupture at site of lower stiffness, i.e., the dermis. This might
be correlated with the higher number of hemidesmosomes
observed in transgenic skin compared with wild type. Our
data provide the in vivo evidence that distinct molecular
forms of a same collagen type can differentially influence
extracellular matrix architecture and mechanical properties.
To our knowledge, this is previously unreported. Regulation
of assembly and disassembly of hemidesmosomes is of
crucial importance in migration of keratinocytes during
biological and pathological processes (Tsuruta et al., 2011).
The increase in the number of hemidesmosmes observed in
the K14-COL5A1 transgenic mice may also have an impact
on their ability to migrate.
The fact that collagens V and VI and tenascin-X are part of the
same protein complex may be correlated with their implication
in identical or overlapping connective tissue disorders. Mutations
in tenascin-X and collagen V genes are both responsible for the
classic form of EDS (Malfait and De Paepe, 2005). The Ullrich
congenital muscular dystrophy caused by mutations in collagen
VI genes exhibits clinical and ultrastructural characteristics
overlapping with classic EDS (Kirschner et al., 2005). Lack of
one of the elements of the protein network we have established
here may destabilize the whole structure and cause defects in
skin cohesion and function.
Overexpression of the transgene in mouse skin also
resulted in the detection of a strong signal of the transgene
product around hair follicle and an unexpected increase in
hair number. Interestingly, a large number of hair follicles
was initially reported in pN/ mouse skin (Andrikopoulos
et al., 1995), and we showed that the targeted deletion in
Col5a2 gene in pN/ mice results in abnormal predominant
deposition of homotrimers into the dermal matrix (Chanut-
Delalande et al., 2004). Thus, the two mouse models provide
corroborative evidence for an unexpected role of collagen V
homotrimer in hair cycling. Control of hair follicle cycling
involves growth factors such as members of the transforming
growth factor-b (TGF-b) (Stenn and Paus, 2001). Although we
did not detect significant change in TGF-b1-3 expression in
transgenic skin (Figure 1b), the possible role of collagen V in
hair cycling deserves further investigation. We recently
reported that TGF-b1 binds to the a1(V) N-propeptide
(Symoens et al., 2010). The bioavailability of TGF-b in skin
can be controlled by the partial N-propeptide cleavage
occurring during pro-chain maturation (Bonod-Bidaud et al.,
2007). Overexpression of the a1(V)3 in the perifollicular zone
may disturb TGF-b delivery, which results in an increase of
hair number.
In conclusion, the generation and analysis of the K14-
COL5A1 mice has shed light on the role of a minor collagen
V subtype in skin development and function. Our data
demonstrated a specific role and distribution for the different
collagen V subtypes in skin as illustrated in Figure 5d and
has sorted out key elements of the native protein network
occurring at the basement membrane zone. The K14-COL5A1
transgenic mouse line we have fully characterized in this study
represents a good model to study the influence of collagen V in
skin wound healing, a reported skin defect in EDS patients.
MATERIALS AND METHODS
Generation of transgenic mouse lines
Transgenic mouse lines (K14-COL5A1) overexpressing the human
proa1(V) chain in the epidermis under the control of the K14
promoter (Vassar et al., 1989) were created and characterized as
described in Supplementary Materials online. Mice were kept
according to French national requirements and all experimental
procedures were approved by the Direction of the Veterinary Service
of Rhone Department (DDSV, Lyon, France).
RT-PCR
Total RNAs were extracted from 17.5 d.p.c. or 5-day-old mouse skin
with the RNeasy kit according to the manufacturer’s instructions
(Qiagen, Hilden, Germany). RT reactions were performed using 1mg
of RNA, with 1mg of 500mM hexameric oligonucleotides and 200U
of Moloney murine leukemia virus enzyme. Col1a1, Col6a1,
Tenascin-X, and Tgfb1-3 were amplified using the primers (to be
continued in Supplementary Materials online).
Immunodetection
Whole protein extracts of 17.5 d.p.c. transgenic and wild-type skin
embryos were analyzed by western blot to detect the transgene-
derived product using specific monoclonal antibodies (see Supple-
mentary Materials online). For histology and immunochemistry,
tissue samples of 5-day-old mice were fixed in 4% paraformal-
dehyde, embedded in paraffin, and processed as detailed in
Supplementary data online.
Measurement of hair number
Depilatory cream was applied on the skin of the back of the
5-day-old mice that were killed. After treatment for 20minutes, hair
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was removed with a scraper. Thereafter, hair follicles were counted
with a stereomicroscope at low magnification. Seven transgenic
mice and four wild-type mice were analyzed, and four different
fields were counted for each mouse.
Transmission and scanning electron microscopy and
immunogold electron microscopy
Routine TEM and scanning electron microscopy methods are
detailed in Supplementary Materials online. For immunogold
electron microscopy, skin from newborn and 7-day-old mice were
sliced into small pieces and fixed in 4% paraformaldehyde and
0.25% glutaraldehyde in 100mM sodium cacodylate buffer, pH 7.4,
at 41C. The samples were rinsed in phosphate-buffered saline (PBS),
dehydrated in an ascending series of ethanol from 30% to 70%, and
embedded in the acrylic resin LR White (London Resin Company,
London, UK). Ultrathin sections were cut with an ultramicrotome
and collected on Formvar carbon-coated nickel grids for immuno-
gold electron microscopy. Furthermore, ultrathin sections were first
incubated with 100mM glycine in PBS for 2minutes, washed twice
with PBS, and incubated with 2% BSA in PBS for 30minutes.
Thereafter, mAbs against the human proa1(V) chain (13F6) diluted
1:50 in 0.2% BSA were incubated for 2 hours. After washing with
PBS, the sections were incubated with gold-conjugated antibodies
against mouse immunoglobulins (12-nm gold particles). Finally, all
sections were rinsed with water and stained with uranyl acetate for
8minutes. Electron micrographs were taken at 80 kV with an EM 410
electron microscope (Philips, Amsterdam, The Netherlands).
Isolation of authentic suprastructures by superparamagnetic
immunobeads
Crude extracts from mouse skin containing suprastructural fragments
obtained by mechanical disruption of tissue were used for isolation
by superparamagnetic immunobeads (Invitrogen, Oslo, Norway;
Kassner et al., 2003). The superparamagnetic polysterene beads
covered with affinity-purified secondary antibodies (anti-rabbit
immunoglobulins) were covalently coupled to primary antibodies
(CO20511, BIOLOGO) against human collagen V as target to
enhance the separation efficiency as previously described (Villone
et al., 2008) (detailed in Supplementary Materials online).
Biomechanical analysis
Stress/strain tests and splitting tests were conducted as described in
Supplementary Materials online.
Protein-binding assays
Protein-binding assays were performed using surface plasmon
resonance in a Biacore Flexchip system (GE Healthcare, Uppsala,
Sweden) using SPR arrays (Faye et al., 2009) or with solid-phase
binding assays as previously described (Rousselle et al., 1997).
Details are provided in Supplementary Materials online.
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